A
Price
$117.98
Change
-$1.19 (-1.00%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
42.66B
50 days until earnings call
SMLR
Price
$37.95
Change
-$0.55 (-1.43%)
Updated
Jun 30, 02:26 PM (EDT)
Capitalization
203.76M
42 days until earnings call
Interact to see
Advertisement

A vs SMLR

Header iconA vs SMLR Comparison
Open Charts A vs SMLRBanner chart's image
Agilent Technologies
Price$117.98
Change-$1.19 (-1.00%)
Volume$24.54K
Capitalization42.66B
Semler Scientific
Price$37.95
Change-$0.55 (-1.43%)
Volume$1.35K
Capitalization203.76M
A vs SMLR Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. SMLR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and SMLR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (A: $119.17 vs. SMLR: $38.50)
Brand notoriety: A and SMLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 84% vs. SMLR: 78%
Market capitalization -- A: $42.66B vs. SMLR: $203.76M
A [@Medical Specialties] is valued at $42.66B. SMLR’s [@Medical Specialties] market capitalization is $203.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileSMLR’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • SMLR’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than SMLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while SMLR’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 4 bearish.
  • SMLR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SMLR is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а +3.12% price change this week, while SMLR (@Medical Specialties) price change was +6.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.48%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was +2.70%.

Reported Earning Dates

A is expected to report earnings on Aug 19, 2025.

SMLR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (+2.48% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than SMLR($204M). A has higher P/E ratio than SMLR: A (34.82) vs SMLR (11.02). A YTD gains are higher at: -11.104 vs. SMLR (-28.704). A has higher annual earnings (EBITDA): 1.69B vs. SMLR (23.6M). SMLR has less debt than A: SMLR (160K) vs A (2.56B). A has higher revenues than SMLR: A (6.74B) vs SMLR (68.2M).
ASMLRA / SMLR
Capitalization42.7B204M20,931%
EBITDA1.69B23.6M7,161%
Gain YTD-11.104-28.70439%
P/E Ratio34.8211.02316%
Revenue6.74B68.2M9,875%
Total CashN/A57.2M-
Total Debt2.56B160K1,596,875%
FUNDAMENTALS RATINGS
A vs SMLR: Fundamental Ratings
A
SMLR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
4795
PRICE GROWTH RATING
1..100
5562
P/E GROWTH RATING
1..100
6284
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for SMLR (64) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than SMLR’s over the last 12 months.

A's Profit vs Risk Rating (66) in the Biotechnology industry is somewhat better than the same rating for SMLR (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than SMLR’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for SMLR (95) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than SMLR’s over the last 12 months.

A's Price Growth Rating (55) in the Biotechnology industry is in the same range as SMLR (62) in the Medical Specialties industry. This means that A’s stock grew similarly to SMLR’s over the last 12 months.

A's P/E Growth Rating (62) in the Biotechnology industry is in the same range as SMLR (84) in the Medical Specialties industry. This means that A’s stock grew similarly to SMLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASMLR
RSI
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
70%
Momentum
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
61%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
60%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSBK36.400.08
+0.22%
Southern States Bancshares
VRRM25.31N/A
N/A
Verra Mobility Corp
DD68.88-0.40
-0.58%
DuPont de Nemours
PERI10.10-0.16
-1.56%
Perion Network Ltd
CPIX2.60-0.08
-2.99%
Cumberland Pharmaceuticals

SMLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMLR has been loosely correlated with NNOX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SMLR jumps, then NNOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMLR
1D Price
Change %
SMLR100%
-0.75%
NNOX - SMLR
46%
Loosely correlated
-0.38%
RSLS - SMLR
44%
Loosely correlated
+2.52%
ITGR - SMLR
40%
Loosely correlated
+0.57%
CERS - SMLR
40%
Loosely correlated
+4.41%
RDNT - SMLR
39%
Loosely correlated
-1.60%
More